kynurenine and oligonucleotides

kynurenine has been researched along with oligonucleotides in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Hinterwimmer, L; Jaschinski, F; Klar, R; Michel, S; Schell, M; Zippelius, A	1

Other Studies

1 other study(ies) available for kynurenine and oligonucleotides

Article	Year
A highly efficient modality to block the degradation of tryptophan for cancer immunotherapy: locked nucleic acid-modified antisense oligonucleotides to inhibit human indoleamine 2,3-dioxygenase 1/tryptophan 2,3-dioxygenase expression. Cancer immunology, immunotherapy : CII, 2020, Volume: 69, Issue:1 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coculture Techniques; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Immunotherapy; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inhibitory Concentration 50; Kynurenine; Lymphocyte Activation; Neoplasms; Oligonucleotides; Oligonucleotides, Antisense; T-Lymphocytes; Tryptophan; Tryptophan Oxygenase	2020

Article

Year

A highly efficient modality to block the degradation of tryptophan for cancer immunotherapy: locked nucleic acid-modified antisense oligonucleotides to inhibit human indoleamine 2,3-dioxygenase 1/tryptophan 2,3-dioxygenase expression.

Cancer immunology, immunotherapy : CII, 2020, Volume: 69, Issue:1

Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coculture Techniques; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Immunotherapy; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inhibitory Concentration 50; Kynurenine; Lymphocyte Activation; Neoplasms; Oligonucleotides; Oligonucleotides, Antisense; T-Lymphocytes; Tryptophan; Tryptophan Oxygenase

2020